{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:12:10Z","timestamp":1776719530258,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biology and Craniofacial Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jobcr.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T04:01:53Z","timestamp":1353643313000},"page":"25-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Dental complications and management of patients on bisphosphonate therapy: A review article"],"prefix":"10.1016","volume":"3","author":[{"given":"Sandeep","family":"Kalra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jobcr.2012.11.001_bib1","first-page":"e65","article-title":"Dental implants in patients treated with oral bisphosphonates: a bibliographic review","volume":"15","author":"Montoya-Carralero","year":"2010","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jobcr.2012.11.001_bib2","first-page":"e755","article-title":"Oral implants in patients receiving bisphosphonates: a review and update","volume":"13","author":"Serra","year":"2008","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jobcr.2012.11.001_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jobcr.2012.11.001_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0169-409X(00)00061-2","article-title":"Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption","volume":"42","author":"Ezra","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jobcr.2012.11.001_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1552-4604.1997.tb04304.x","article-title":"Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function","volume":"37","author":"Berenson","year":"1997","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jobcr.2012.11.001_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jobcr.2012.11.001_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1592\/phco.28.5.667","article-title":"Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates","volume":"28","author":"King","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jobcr.2012.11.001_bib9","first-page":"96","article-title":"Bisphosphonate-related osteonecrosis of the jaws","volume":"29","author":"Ruggiero","year":"2008","journal-title":"Compend Contin Educ Dent"},{"key":"10.1016\/j.jobcr.2012.11.001_bib10","series-title":"Skeletal Biology and Medicine","first-page":"209","article-title":"Bisphosphonates.An update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007"},{"key":"10.1016\/j.jobcr.2012.11.001_bib11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate induced exposed bone (osteonecrosis\/osteoporosis) of the jaws: risk factors, recognition, prevention and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jobcr.2012.11.001_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/asheducation-2006.1.356","article-title":"Bisphosphonate complications including osteonecrosis of the jaw","author":"Mehrotra","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jobcr.2012.11.001_bib13","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis","volume":"136","author":"Migiliorati","year":"2005","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jobcr.2012.11.001_bib14","first-page":"1890","article-title":"Bisphosphonate modulates cementoblast behaviour in\u00a0vitro","volume":"76","author":"Chun","year":"2005","journal-title":"J\u00a0Periodontol"},{"issue":"6","key":"10.1016\/j.jobcr.2012.11.001_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib16","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bannias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib17","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Hematologica"},{"key":"10.1016\/j.jobcr.2012.11.001_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: bisphosphonates and osteonecrosis of the jaw","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jobcr.2012.11.001_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jobcr.2012.11.001_bib20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.leu.2404682","article-title":"A\u00a0different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma","volume":"21","author":"Corso","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jobcr.2012.11.001_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jobcr.2012.11.001_bib22","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate related osteonecrosis of the jaws: risk factors in breast cancer patients. A case control study","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib23","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","article-title":"A\u00a0retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","article-title":"\u201cBis-phossy jaws\u201d\u2014high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw","volume":"36","author":"Abu-Id","year":"2008","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jobcr.2012.11.001_bib25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jobcr.2012.11.001_bib26","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jobcr.2012.11.001_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","article-title":"Bisphosphonate-Induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene","volume":"67","author":"Lehrer","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jobcr.2012.11.001_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study","volume":"66","author":"Wessel","year":"2008","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jobcr.2012.11.001_bib29","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/annonc\/mdl045","article-title":"Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?","volume":"17","author":"Ardine","year":"2006","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jobcr.2012.11.001_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jobcr.2012.11.001_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.amjmed.2008.01.047","article-title":"Factors associated with osteonecrosis of the jaw among bisphosphonate users","volume":"121","author":"Hess","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jobcr.2012.11.001_bib32","series-title":"Recommendation for Prevention, Diagnosis and Treatment of Osteonecrosis of Jaws (Expert Panel)","author":"Damata","year":"2004"},{"key":"10.1016\/j.jobcr.2012.11.001_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for prevention, diagnosis and treatment of osteonecrosis of jaw in patient with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.jobcr.2012.11.001_bib34","first-page":"3357","article-title":"Early changes in serum N-telopeptide and C- telopeptide cross linked collagen type I predict long term response to alendronate therapy in elderly women","volume":"85","author":"Greenspan","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jobcr.2012.11.001_bib35","doi-asserted-by":"crossref","unstructured":"American Association of Endodontists Position Statement. Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws. Available at: http:\/\/www.aae.org\/dentalpro\/guidelines.htm. Accessed on 14.08.2006.","DOI":"10.1016\/S0084-3717(08)70223-X"},{"key":"10.1016\/j.jobcr.2012.11.001_bib36","first-page":"349","article-title":"Safety of oral bisphosphonates: controlled studies on alveolar bone","volume":"21","author":"Jeffcoat","year":"2006","journal-title":"Int J Oral Maxillofac Implants"},{"key":"10.1016\/j.jobcr.2012.11.001_bib37","first-page":"584","article-title":"Effect of long term oral bisphosphonates on implant wound healing: literature review and a case report","volume":"78","author":"Wang","year":"2007","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib38","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jobcr.2012.11.001_bib39","first-page":"1664","article-title":"Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices","volume":"78","author":"Fugazzoto","year":"2007","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.jobcr.2012.11.001_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.joms.2007.09.019","article-title":"Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases","volume":"66","author":"Grant","year":"2008","journal-title":"J\u00a0Oral Maxillofac Surg"}],"container-title":["Journal of Oral Biology and Craniofacial Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426812000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426812000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:20:27Z","timestamp":1761945627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212426812000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S2212426812000747"],"URL":"https:\/\/doi.org\/10.1016\/j.jobcr.2012.11.001","relation":{},"ISSN":["2212-4268"],"issn-type":[{"value":"2212-4268","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dental complications and management of patients on bisphosphonate therapy: A review article","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biology and Craniofacial Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jobcr.2012.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}